Form 4 for MRNA Moderna
Accepted 2023-02-17 00:00:00 ET · period of report 2023-02-15 · accession 0001127602-23-005814 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-02-17 | 2023-02-15+ | MRNA | Bancel Stephane | CEO, Dir | S - Sale+OE | $174.02 | -80.0K | 5.41M | -1% | -$13.92M |
| DM | 2023-02-17 | 2023-02-15+ | MRNA | Bancel Stephane | CEO, Dir | M - OptEx | $0.99 | +80.0K | 5.45M | +1% | +$79.2K |
| DM | 2023-02-17 | 2023-02-15+ | MRNA | Bancel Stephane | CEO, Dir | M - OptEx | $0.00 | -80.0K | 1.51M | -5% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-02-16 | S | D | 28,331 | $173.30 | 5,414,663 | D | — | — | (F7) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $172.70 to $173.70. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. |
| 2 | Common | Common Stock | 2023-02-16 | S | D | 8,952 | $172.14 | 5,442,994 | D | — | — | (F6) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $171.67 to $172.67. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. |
| 3 | Common | Common Stock | 2023-02-15 | S | D | 14,812 | $175.85 | 5,413,432 | D | — | — | (F4) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $175.39 to $176.38. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. |
| 4 | Common | Common Stock | 2023-02-15 | S | D | 1,486 | $176.73 | 5,411,946 | D | — | — | (F5) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $176.47 to $176.91. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. |
| 5 | Common | Common Stock | 2023-02-15 | M | A | 40,000 | $0.99 | 5,451,946 | D | — | — | |
| 6 | Common | Common Stock | 2023-02-15 | S | D | 10,327 | $173.68 | 5,441,619 | D | — | — | (F2) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $173.36 to $174.36. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. |
| 7 | Common | Common Stock | 2023-02-15 | S | D | 13,375 | $174.77 | 5,428,244 | D | — | — | (F3) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $174.37 to $175.34. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. |
| 8 | Common | Common Stock | 2023-02-16 | S | D | 2,717 | $173.79 | 5,411,946 | D | — | — | (F8) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $173.71 to $173.91. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. |
| 9 | Common | Common Stock | 2023-02-16 | M | A | 40,000 | $0.99 | 5,451,946 | D | — | — | |
| 10 | Derivative | Stock Option (Right to Buy) | 2023-02-16 | M | D | 40,000 | $0.00 | 1,467,155 | D | $0.99 · — to 2023-08-19 | 40,000 Common Stock | (F11) This option is fully vested and exercisable. |
| 11 | Derivative | Stock Option (Right to Buy) | 2023-02-15 | M | D | 40,000 | $0.00 | 1,507,155 | D | $0.99 · — to 2023-08-19 | 40,000 Common Stock | (F11) This option is fully vested and exercisable. |